Correction to: GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2840
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Correction to: GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data ; volume:18 ; number:1 ; day:1 ; month:3 ; year:2019 ; pages:1-3 ; date:12.2019
Cardiovascular diabetology ; 18, Heft 1 (1.3.2019), 1-3, 12.2019
- Urheber
-
Sposito, Andrei C.
Berwanger, Otávio
Carvalho, Luiz Sérgio F. de
Saraiva, José Francisco Kerr
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12933-019-0825-1
- URN
-
urn:nbn:de:101:1-2019032619303262358767
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sposito, Andrei C.
- Berwanger, Otávio
- Carvalho, Luiz Sérgio F. de
- Saraiva, José Francisco Kerr
- SpringerLink (Online service)
Ähnliche Objekte (12)
GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data
DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits
Shared genetic factors between osteoarthritis and cardiovascular disease may underlie common etiology
Cardiovascular stents: overview, evolution, and next generation
Cardiovascular Benefits of GLP-1 Receptor Agonism: Is Inflammation a Key?
GLP-1RAs and cardiovascular disease: is the endothelium a relevant platform?
Heterogeneity amongst GLP-1 RA cardiovascular outcome trials results: can definition of established cardiovascular disease be the missing link?
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
Cardiovascular Complications of SARS-CoV-2 Vaccines: An Overview
The molecular mechanisms that underlie neural network assembly
Distinct biological signature and modifiable risk factors underlie the comorbidity between major depressive disorder and cardiovascular disease
Underlying mechanisms and cardioprotective effects of SGLT2i and GLP-1Ra: insights from cardiovascular magnetic resonance
GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data
DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits
Shared genetic factors between osteoarthritis and cardiovascular disease may underlie common etiology
Cardiovascular stents: overview, evolution, and next generation
Cardiovascular Benefits of GLP-1 Receptor Agonism: Is Inflammation a Key?
GLP-1RAs and cardiovascular disease: is the endothelium a relevant platform?
Heterogeneity amongst GLP-1 RA cardiovascular outcome trials results: can definition of established cardiovascular disease be the missing link?
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
Cardiovascular Complications of SARS-CoV-2 Vaccines: An Overview
The molecular mechanisms that underlie neural network assembly
Distinct biological signature and modifiable risk factors underlie the comorbidity between major depressive disorder and cardiovascular disease
Underlying mechanisms and cardioprotective effects of SGLT2i and GLP-1Ra: insights from cardiovascular magnetic resonance
GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data
DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits
Shared genetic factors between osteoarthritis and cardiovascular disease may underlie common etiology
Cardiovascular stents: overview, evolution, and next generation
Cardiovascular Benefits of GLP-1 Receptor Agonism: Is Inflammation a Key?
GLP-1RAs and cardiovascular disease: is the endothelium a relevant platform?
Heterogeneity amongst GLP-1 RA cardiovascular outcome trials results: can definition of established cardiovascular disease be the missing link?
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
Cardiovascular Complications of SARS-CoV-2 Vaccines: An Overview
The molecular mechanisms that underlie neural network assembly
Distinct biological signature and modifiable risk factors underlie the comorbidity between major depressive disorder and cardiovascular disease